Literature DB >> 29954934

Impact of Sox11 over-expression in Ba/F3 cells.

Martin Lord1, Gustav Arvidsson2, Agata M Wasik1, Birger Christensson1, Anthony P Wright2, Alf Grandien3, Birgitta Sander4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29954934      PMCID： PMC6269285          DOI： 10.3324/haematol.2018.197467

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.

Authors:  Christian Korz; Armin Pscherer; Axel Benner; Daniel Mertens; Claudia Schaffner; Elke Leupolt; Hartmut Döhner; Stephan Stilgenbauer; Peter Lichter
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

2.  High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.

Authors:  P-Y Kuo; V V Leshchenko; M J Fazzari; D Perumal; T Gellen; T He; J Iqbal; S Baumgartner-Wennerholm; L Nygren; F Zhang; W Zhang; K S Suh; A Goy; D T Yang; W-C Chan; B S Kahl; A K Verma; R D Gascoyne; E Kimby; B Sander; B H Ye; A M Melnick; S Parekh
Journal:  Oncogene       Date:  2014-03-31       Impact factor: 9.867

3.  The utility of mRNA analysis in defining SOX11 expression levels in mantle cell lymphoma and reactive lymph nodes.

Authors:  Martin Lord; Agata M Wasik; Birger Christensson; Birgitta Sander
Journal:  Haematologica       Date:  2015-04-17       Impact factor: 9.941

4.  SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis.

Authors:  Lifang Mu; Lucia Berti; Giacomo Masserdotti; Marcela Covic; Theologos M Michaelidis; Kathrin Doberauer; Katharina Merz; Frederick Rehfeld; Anja Haslinger; Michael Wegner; Elisabeth Sock; Veronique Lefebvre; Sebastien Couillard-Despres; Ludwig Aigner; Benedikt Berninger; D Chichung Lie
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

5.  SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.

Authors:  Maria Carmela Vegliante; Jara Palomero; Patricia Pérez-Galán; Gaël Roué; Giancarlo Castellano; Alba Navarro; Guillem Clot; Alexandra Moros; Helena Suárez-Cisneros; Sílvia Beà; Luis Hernández; Anna Enjuanes; Pedro Jares; Neus Villamor; Dolors Colomer; José Ignacio Martín-Subero; Elias Campo; Virginia Amador
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

6.  Sox4 is required for the survival of pro-B cells.

Authors:  Baohua Sun; Saradhi Mallampati; Yun Gong; Donghai Wang; Véronique Lefebvre; Xiaoping Sun
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

7.  Sox11 gene disruption causes congenital anomalies of the kidney and urinary tract (CAKUT).

Authors:  Yasmine Neirijnck; Antoine Reginensi; Kirsten Y Renkema; Filippo Massa; Vladimir M Kozlov; Haroun Dhib; Ernie M H F Bongers; Wout F Feitz; Albertien M van Eerde; Veronique Lefebvre; Nine V A M Knoers; Mansoureh Tabatabaei; Herbert Schulz; Helen McNeill; Franz Schaefer; Michael Wegner; Elisabeth Sock; Andreas Schedl
Journal:  Kidney Int       Date:  2018-02-17       Impact factor: 10.612

8.  SOX11 augments BCR signaling to drive MCL-like tumor development.

Authors:  Pei-Yu Kuo; Shashidhar S Jatiani; Adeeb H Rahman; Donna Edwards; Zewei Jiang; Katya Ahr; Deepak Perumal; Violetta V Leshchenko; Joshua Brody; Rita Shaknovich; B Hilda Ye; Samir Parekh
Journal:  Blood       Date:  2018-04-03       Impact factor: 22.113

9.  The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.

Authors:  Jonathan H Shepherd; Ivan P Uray; Abhijit Mazumdar; Anna Tsimelzon; Michelle Savage; Susan G Hilsenbeck; Powel H Brown
Journal:  Oncotarget       Date:  2016-03-15

10.  Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.

Authors:  Ali Khammanivong; Brent S Sorenson; Karen F Ross; Erin B Dickerson; Rifat Hasina; Mark W Lingen; Mark C Herzberg
Journal:  Oncotarget       Date:  2016-03-22
View more
  2 in total

1.  Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia.

Authors:  Toni Grönroos; Artturi Mäkinen; Saara Laukkanen; Juha Mehtonen; Atte Nikkilä; Laura Oksa; Samuli Rounioja; Yanara Marincevic-Zuniga; Jessica Nordlund; Virva Pohjolainen; Timo Paavonen; Merja Heinäniemi; Olli Lohi
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

2.  WX-0593 combined with an epithelial growth factor receptor (EGFR) monoclonal antibody in the treatment of xenograft tumors carrying triple EGFR mutations.

Authors:  Qingmei Zheng; Dongmei Chen; Xinmei Wang; Yingying Yang; Shuyong Zhao; Xin Dong; Cuicui Ma; Xin Zhang; Huicheng Duan; Yan Sun; Shansong Zheng
Journal:  Ann Transl Med       Date:  2022-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.